Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA adjunct to oral contraceptives for reduced libido associated with oral contraceptive use
2006-004397-27Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2009
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) and female sexual dysfunction (FSD) comparing Prasterone + oral contraceptive with Placebo + oral contraceptive (2 arms). Primary endpoint: Change in combined FSFI desire and arousal score. Started Apr 2009; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)female sexual dysfunction (FSD)
Beyond the preview
Go deeper on 2006-004397-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004397-27.